Failure of activated charcoal to reduce the release of gases produced by the colonic flora
- PMID: 9934757
- DOI: 10.1111/j.1572-0241.1999.00798.x
Failure of activated charcoal to reduce the release of gases produced by the colonic flora
Abstract
Objective: Activated charcoal is used to treat excessive volume or malodor of intestinal gas. Our previous studies demonstrated that activated charcoal failed to bind appreciable quantities of the volumetrically important gut gases. However, the odor of feces and flatus derives primarily from trace quantities of sulfur-containing gases, primarily H2S and methanethiol, which should avidly bind to activated charcoal. The goal of this study was to determine if ingestion of activated charcoal reduces the fecal release of sulfur gases.
Methods: Five healthy human volunteers ingested 0.52 g of activated charcoal four times daily for 1 wk and the fecal liberation of intestinal gases was measured before and after the activated charcoal treatment. In an effort to explain the in vivo results, additional in vitro studies were performed to compare the binding capacity of charcoal to the sulfur gas released by feces.
Results: Ingestion of activated charcoal produced no significant reduction in the fecal release of any of the sulfur-containing gases, nor was total fecal gas release or abdominal symptoms significantly influenced. In vitro studies suggested that the failure of ingested charcoal to reduce liberation of sulfur gases probably is explained by the saturation of charcoal binding sites during passage through the gut.
Conclusion: Commonly employed doses of activated charcoal do not appreciably influence the liberation of fecal gases.
Similar articles
-
Identification of gases responsible for the odour of human flatus and evaluation of a device purported to reduce this odour.Gut. 1998 Jul;43(1):100-4. doi: 10.1136/gut.43.1.100. Gut. 1998. PMID: 9771412 Free PMC article.
-
Fecal hydrogen sulfide production in ulcerative colitis.Am J Gastroenterol. 1998 Jan;93(1):83-7. doi: 10.1111/j.1572-0241.1998.083_c.x. Am J Gastroenterol. 1998. PMID: 9448181
-
Association between fecal hydrogen sulfide production and pouchitis.Dis Colon Rectum. 2005 Mar;48(3):469-75. doi: 10.1007/s10350-004-0820-8. Dis Colon Rectum. 2005. PMID: 15747080
-
Luminal sulfide and large intestine mucosa: friend or foe?Amino Acids. 2010 Jul;39(2):335-47. doi: 10.1007/s00726-009-0445-2. Epub 2009 Dec 18. Amino Acids. 2010. PMID: 20020161 Review.
-
[Hydrogen metabolism in the large intestine--physiology and clinical implications].Z Gastroenterol. 1995 Jul;33(7):408-13. Z Gastroenterol. 1995. PMID: 7571760 Review. German.
Cited by
-
Gas and Bloating.Gastroenterol Hepatol (N Y). 2006 Sep;2(9):654-662. Gastroenterol Hepatol (N Y). 2006. PMID: 28316536 Free PMC article.
-
Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial.BMC Gastroenterol. 2013 Sep 24;13:142. doi: 10.1186/1471-230X-13-142. BMC Gastroenterol. 2013. PMID: 24063420 Free PMC article. Clinical Trial.
-
Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air?Gastroenterol Hepatol (N Y). 2011 Nov;7(11):729-39. Gastroenterol Hepatol (N Y). 2011. PMID: 22298969 Free PMC article.
-
Genomic insights into bifidobacteria.Microbiol Mol Biol Rev. 2010 Sep;74(3):378-416. doi: 10.1128/MMBR.00004-10. Microbiol Mol Biol Rev. 2010. PMID: 20805404 Free PMC article. Review.
-
Bloating and intestinal gas.Curr Treat Options Gastroenterol. 2005 Aug;8(4):311-8. doi: 10.1007/s11938-005-0024-x. Curr Treat Options Gastroenterol. 2005. PMID: 16009032
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
Medical
